Tsakalozou, Eleftheria
Mohamed, Mohamed-Eslam F.
Polak, Sebastian
Heimbach, Tycho
Article History
Received: 25 July 2023
Accepted: 16 September 2023
First Online: 2 October 2023
Declarations
:
: Mohamed-Eslam F. Mohamed is an employee and shareholder of AbbVie, Inc. All other authors declared no competing interests for this work.
: The opinions expressed in the manuscript are those of the authors and should not be interpreted as the position of their organizations/employers. The opinions expressed in the manuscript are those of the authors and should not be interpreted as the position of the US Food and Drug Administration.